ILMN
Illumina, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Strong buy
+57/100
Last price
273.00
▼ 20.69 (7.04%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
294.20
Prev close
293.69
Day high
309.35
Day low
271.55
Volume
4.38M
Market cap
$41.30B
P/E (TTM)
51.03
52W range
88.00 – 309.35
Day trading desk
Gap from prior close
+0.17%
Prior close 293.69
VWAP
277.85
-1.75% from price
Relative volume
3.10×
Unusually busy
Session range
15.42%
268.01 – 309.35
Position in range
12%
Near session low
ATR (14D)
15.47
5.67% of price
Prior day high
296.25
PDH
Prior day low
271.61
PDL
Bid / ask spread
—
Quote not published
Session volume
8.23M
Avg 2.66M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.57%
-1.4%
1M
+25.35%
+24.2%
3M
+45.65%
+41.1%
6M
+116.34%
+98.2%
YTD
+108.55%
+94.3%
1Y
+167.86%
+151.4%
3Y
+104.84%
+22.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ILMN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-2.66M
Net selling
Buy transactions
16
410.57K shares
Sell transactions
14
3.07M shares
Net transactions
+30
Buys less sells
Sell : buy shares
7.5 : 1
Heavily one-sided
Insider-held shares
317.10K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 8, 26 | COLETTI JULIE ANN Officer |
STOCK | 18.76K | $0 | Direct |
| Sep 4, 26 | MEISTER KEITH A Director |
SELL | 263.56K | $57.20M | Indirect |
| Aug 27, 26 | MEISTER KEITH A Director |
SELL | 375.94K | $85.24M | Indirect |
| Aug 21, 26 | MEISTER KEITH A Director |
SELL | 679.57K | $145.56M | Indirect |
| Aug 18, 26 | WEDEL CHRISTENSEN JAKOB Officer |
SELL | 1.03K | $197.84K | Direct |
| Aug 5, 26 | SULLIVAN MICHAEL C Officer |
STOCK | 4.50K | $900.01K | Direct |
| Aug 5, 26 | MEISTER KEITH A Director |
SELL | 741.13K | $148.16M | Indirect |
| Jul 30, 26 | DAVIES SCOTT M Officer |
SELL | 615 | $123.00K | Direct |
| Jun 30, 26 | MEISTER KEITH A Director |
STOCK | 142 | $21.18K | Direct |
| Jun 30, 26 | ULLEM SCOTT B Director |
STOCK | 167 | $24.91K | Direct |
| Jun 25, 26 | DAVIES SCOTT M Officer |
SELL | 615 | $110.70K | Direct |
| Jun 16, 26 | SKOVRONSKY DANIEL Director |
STOCK | 1.67K | $275.00K | Direct |
| Jun 5, 26 | LECKMAN PATRICIA L Officer |
SELL | 783 | $127.31K | Direct |
| Jun 2, 26 | LECKMAN PATRICIA L Officer |
SELL | 784 | $127.07K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ARNOLD FRANCES H PH.D. |
Director | 20.91K | Stock Award(Grant) |
BARNARD STEVEN |
Chief Technology Officer | 41.34K | Stock Award(Grant) |
CUNNINGHAM EVERETT V |
Officer | 50.84K | Stock Award(Grant) |
DHINGRA ANKUR |
Chief Financial Officer | 34.26K | Stock Award(Grant) |
EPSTEIN ROBERT S |
Director | 22.14K | Stock Award(Grant) |
LECKMAN PATRICIA L |
Officer | 21.26K | Sale |
MEISTER KEITH A |
Director | — | Sale |
PEGELS KEVIN CARL |
Officer | 29.04K | Stock Award(Grant) |
SCHILLER PHILIP W |
Director | 22.22K | Stock Award(Grant) |
THAYSEN JACOB |
Chief Executive Officer | 109.07K | Stock Award(Grant) |
Fundamentals
Market cap$41.30B
Enterprise value$42.66B
Revenue (TTM)$4.49B
Gross profit$3.05B
EBITDA$1.16B
Net income$824.00M
EPS (TTM)$5.36
Free cash flow$797.63M
Total cash$1.17B
Total debt$2.53B
Book value / share$18.80
Shares outstanding151.00M
Float149.78M
Short % of float11.47%
Dividend yield0.00%
Beta (5Y)1.42
Valuation & profitability ratios
Trailing P/E51.03
Forward P/E44.80
PEG ratio3.62
Price / sales—
Price / book14.55
EV / revenue9.49
EV / EBITDA36.94
Gross margin67.93%
Operating margin21.14%
Profit margin18.34%
Return on equity32.34%
Return on assets8.67%
Debt / equity89.04
Current ratio1.80
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $4.34B | $4.37B | $4.50B | $4.58B | -0.7% |
| Operating revenue | $4.34B | $4.37B | $4.50B | $4.58B | -0.7% |
| Cost of revenue | $1.47B | $1.51B | $1.76B | $1.61B | -2.5% |
| Gross profit | $2.87B | $2.86B | $2.74B | $2.97B | +0.3% |
| Research & development | $967.00M | $1.17B | $1.35B | $1.32B | -17.3% |
| Selling, general & admin | $1.09B | $1.09B | $1.61B | $1.30B | -0.5% |
| Total operating expense | $2.05B | $2.26B | $2.97B | $2.62B | -9.2% |
| Operating income | $817.00M | $600.00M | -$222.00M | $354.00M | +36.2% |
| Net interest income | -$61.00M | -$54.00M | -$19.00M | -$15.00M | -13.0% |
| Pre-tax income | $1.09B | -$1.18B | -$1.12B | -$4.34B | +192.1% |
| Tax provision | $236.00M | $44.00M | $44.00M | $68.00M | +436.4% |
| Net income | $850.00M | -$1.22B | -$1.16B | -$4.40B | +169.5% |
| Net income to common | $850.00M | -$1.22B | -$1.16B | -$4.40B | +169.5% |
| Basic EPS | 5.47 | -7.69 | -7.34 | -28.00 | +171.1% |
| Diluted EPS | 5.45 | -7.69 | -7.34 | -28.00 | +170.9% |
| EBIT | $1.19B | -$1.08B | -$1.04B | -$4.31B | +210.0% |
| EBITDA | $1.46B | -$725.00M | -$608.00M | -$3.92B | +301.0% |
| Basic shares | 155.00M | 159.00M | 158.00M | 157.00M | -2.5% |
| Diluted shares | 156.00M | 159.00M | 158.00M | 157.00M | -1.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.42B | $1.13B | $1.05B | $2.01B | +25.8% |
| Cash & short-term investments | $1.63B | $1.22B | $1.05B | $2.04B | +33.9% |
| Accounts receivable | $854.00M | $735.00M | $734.00M | $671.00M | +16.2% |
| Inventory | $564.00M | $547.00M | $587.00M | $568.00M | +3.1% |
| Total current assets | $3.29B | $2.75B | $2.61B | $3.56B | +19.8% |
| Property, plant & equipment | $1.13B | $1.23B | $1.55B | $1.74B | -8.5% |
| Goodwill & intangibles | $1.32B | $1.41B | $5.54B | $6.52B | -6.0% |
| Total assets | $6.64B | $6.30B | $10.11B | $12.25B | +5.4% |
| Total current liabilities | $1.58B | $1.55B | $1.57B | $2.77B | +2.5% |
| Current debt | $499.00M | $499.00M | — | $1.25B | 0.0% |
| Long-term debt | $1.49B | $1.49B | $1.49B | $1.49B | 0.0% |
| Total debt | $2.55B | $2.62B | $2.26B | $3.56B | -2.6% |
| Total liabilities | $3.92B | $3.93B | $4.37B | $5.65B | -0.2% |
| Retained earnings | -$392.00M | -$1.24B | -$19.00M | $1.14B | +68.4% |
| Shareholder equity | $2.72B | $2.37B | $5.75B | $6.60B | +14.7% |
| Working capital | $1.70B | $1.20B | $1.04B | $788.00M | +42.1% |
| Net tangible assets | $1.40B | $965.00M | $207.00M | $75.00M | +45.1% |
| Shares issued | 201.00M | 200.00M | 199.00M | 198.00M | +0.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $850.00M | -$1.22B | -$1.16B | -$4.40B | +169.5% |
| Depreciation & amortisation | $270.00M | $354.00M | $432.00M | $394.00M | -23.7% |
| Stock-based compensation | $275.00M | $370.00M | $380.00M | $366.00M | -25.7% |
| Change in working capital | -$153.00M | -$483.00M | -$90.00M | $204.00M | +68.3% |
| Operating cash flow | $1.08B | $837.00M | $478.00M | $392.00M | +28.9% |
| Capital expenditure | -$148.00M | -$128.00M | -$195.00M | -$286.00M | -15.6% |
| Investing cash flow | -$55.00M | -$178.00M | -$231.00M | -$591.00M | +69.1% |
| Share buybacks | -$742.00M | -$116.00M | $0 | $0 | -539.7% |
| Financing cash flow | -$744.00M | -$570.00M | -$1.21B | $1.00B | -30.5% |
| Free cash flow | $931.00M | $709.00M | $283.00M | $106.00M | +31.3% |
| End cash position | $1.42B | $1.13B | $1.05B | $2.01B | +25.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | — | $1.09B | $1.16B | $1.08B | $1.06B | $1.04B | — |
| Operating revenue | — | $1.09B | $1.16B | $1.08B | $1.06B | $1.04B | — |
| Cost of revenue | — | $370.00M | $400.00M | $351.00M | $364.00M | $358.00M | — |
| Gross profit | — | $721.00M | $759.00M | $733.00M | $695.00M | $683.00M | — |
| Research & development | — | $240.00M | $239.00M | $229.00M | $247.00M | $252.00M | — |
| Selling, general & admin | — | $272.00M | $309.00M | $277.00M | $234.00M | $267.00M | — |
| Total operating expense | — | $512.00M | $548.00M | $506.00M | $481.00M | $519.00M | — |
| Operating income | — | $209.00M | $211.00M | $227.00M | $214.00M | $164.00M | — |
| Net interest income | — | -$13.00M | -$16.00M | -$16.00M | -$15.00M | -$14.00M | — |
| Pre-tax income | — | $157.00M | $377.00M | $220.00M | $306.00M | $182.00M | — |
| Tax provision | — | $23.00M | $43.00M | $70.00M | $71.00M | $51.00M | — |
| Net income | — | $134.00M | $334.00M | $150.00M | $235.00M | $131.00M | — |
| Net income to common | — | $134.00M | $334.00M | $150.00M | $235.00M | $131.00M | — |
| Basic EPS | 1.37 | 0.88 | 2.18 | 0.98 | 1.49 | — | +55.7% |
| Diluted EPS | 1.35 | 0.87 | 2.16 | 0.98 | 1.49 | — | +55.2% |
| EBIT | — | $181.00M | $403.00M | $245.00M | $331.00M | $207.00M | — |
| EBITDA | — | $250.00M | $469.00M | $312.00M | $399.00M | $276.00M | — |
| Basic shares | 151.00M | 153.00M | 153.00M | 153.00M | 157.00M | — | -1.3% |
| Diluted shares | 153.00M | 154.00M | 154.00M | 154.00M | 157.00M | — | -0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | $1.09B | $1.42B | $1.05B | $934.00M | $1.11B | — |
| Cash & short-term investments | — | $1.16B | $1.63B | $1.28B | $1.16B | $1.24B | — |
| Accounts receivable | — | $738.00M | $854.00M | $729.00M | $701.00M | $699.00M | — |
| Inventory | — | $611.00M | $564.00M | $590.00M | $575.00M | $537.00M | — |
| Total current assets | — | $2.74B | $3.29B | $2.80B | $2.64B | $2.67B | — |
| Property, plant & equipment | — | $1.13B | $1.13B | $1.13B | $1.16B | $1.19B | — |
| Goodwill & intangibles | — | $1.71B | $1.32B | $1.34B | $1.35B | $1.39B | — |
| Total assets | — | $6.56B | $6.64B | $6.18B | $6.09B | $6.18B | — |
| Total current liabilities | — | $1.57B | $1.58B | $1.96B | $1.46B | $1.44B | — |
| Current debt | — | $499.00M | $499.00M | $998.00M | $499.00M | $499.00M | — |
| Long-term debt | — | $1.49B | $1.49B | $994.00M | $1.49B | $1.49B | — |
| Total debt | — | $2.54B | $2.55B | $2.58B | $2.60B | $2.61B | — |
| Total liabilities | — | $3.88B | $3.92B | $3.80B | $3.83B | $3.81B | — |
| Retained earnings | — | -$258.00M | -$392.00M | -$726.00M | -$876.00M | -$1.11B | — |
| Shareholder equity | — | $2.68B | $2.72B | $2.38B | $2.26B | $2.37B | — |
| Working capital | — | $1.17B | $1.70B | $834.00M | $1.18B | $1.23B | — |
| Shares issued | 151.00M | 201.00M | 201.00M | 201.00M | 159.00M | — | -24.9% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $134.00M | $334.00M | $150.00M | $235.00M | $131.00M | -59.9% |
| Depreciation & amortisation | $69.00M | $66.00M | $67.00M | $68.00M | $69.00M | +4.5% |
| Stock-based compensation | $60.00M | $63.00M | $70.00M | $69.00M | $73.00M | -4.8% |
| Change in working capital | -$1.00M | -$18.00M | -$56.00M | -$75.00M | -$4.00M | +94.4% |
| Operating cash flow | $289.00M | $321.00M | $284.00M | $234.00M | $240.00M | -10.0% |
| Capital expenditure | -$38.00M | -$55.00M | -$31.00M | -$37.00M | -$32.00M | +30.9% |
| Investing cash flow | -$366.00M | $108.00M | -$51.00M | -$49.00M | -$63.00M | -438.9% |
| Share buybacks | -$242.00M | -$42.00M | -$130.00M | -$370.00M | -$200.00M | -476.2% |
| Financing cash flow | -$251.00M | -$63.00M | -$115.00M | -$371.00M | -$195.00M | -298.4% |
| Free cash flow | $251.00M | $266.00M | $253.00M | $197.00M | $208.00M | -5.6% |
| End cash position | $1.09B | $1.42B | $1.05B | $934.00M | $1.11B | -23.2% |
Options analytics
Put / call volume
1.87
Put-heavy session
Put / call open interest
1.37
Positioning, not flow
Max pain
250.00
-8.6% from spot
ATM implied vol
62.1%
Nearest strike to spot
Skew (10% OTM)
-8.3%
Calls bid over puts
Call volume
1.02K
Contracts, this expiry
Put volume
1.91K
Contracts, this expiry
Heaviest call OI
240.00
485 contracts
Heaviest put OI
240.00
1.03K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.23 | 1.31 | +6.8% |
| Mar 2026 | 1.05 | 1.15 | +9.0% |
| Dec 2025 | 1.23 | 1.35 | +9.7% |
| Sep 2025 | 1.17 | 1.34 | +14.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.36 | 19 | $1.15B | +6.3% |
| Next quarter | 1.54 | 18 | $1.22B | +5.3% |
| Current year | 5.36 | 21 | $4.62B | +6.5% |
| Next year | 6.11 | 21 | $4.92B | +6.4% |
Analyst targets & ownership
Mean target$223.85
High target$310.00
Low target$113.00
Implied upside-18.00%
Analyst count20
ConsensusBUY
Strong buy / Buy4 / 7
Hold6
Sell / Strong sell2 / 2
Held by insiders0.21%
Held by institutions106.34%
Institutions holding1.32K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
272.29
+0.26% from price
SMA 20
248.30
+10.16% from price
SMA 50
222.56
+22.90% from price
SMA 100
196.70
+38.79% from price
SMA 200
164.23
+66.56% from price
EMA 12
265.91
+2.66% from price
EMA 26
248.06
+10.06% from price
EMA 50
228.77
+19.33% from price
RSI (14)
62.8
Neutral
MACD (12,26,9)
17.86
Hist 1.91
ATR (14)
15.47
5.65% of price
Realised vol 30D
56.7%
Annualised
Bollinger upper
303.49
20, 2σ
Bollinger lower
193.12
20, 2σ
50 / 200 cross
Golden
222.56 vs 164.23
Trend bias
Above 200
+66.56%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.78
Less volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
56.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-25.7%
Peak to trough
Max drawdown 5Y
-82.9%
Peak to trough
ATR 14
15.47
5.65% of price
Beta (reported)
1.42
5Y monthly, from filing
Short interest
Shares short
10.59M
Prior 9.46M
Change vs prior
+11.8%
Shorts adding
% of float
11.47%
Elevated
% of shares out
7.01%
Against total outstanding
Days to cover
5.5
Crowded exit
Float
149.78M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Oct 1, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Sep 29, 26 | Leerink Partners | MAINTAINED | Outperform | Outperform |
| Sep 28, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Sep 9, 26 | UBS | UPGRADE | Neutral | Buy |
| Sep 3, 26 | Argus Research | MAINTAINED | Buy | Buy |
| Aug 3, 26 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Aug 3, 26 | Citigroup | MAINTAINED | Sell | Sell |
| Aug 3, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 31, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | TD Cowen | MAINTAINED | Hold | Hold |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1028:1000
Split dateJun 25, 2024
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-17
Corporate Changes & Voting Matters
8-K · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-08-12
Corporate Changes & Voting Matters
8-K · 2026-08-07
Periodic Financial Reports
10-Q · 2026-07-31
Corporate Changes & Voting Matters
8-K · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-06-23
Corporate Changes & Voting Matters
8-K · 2026-05-26
Headlines
Stocks making big moves yesterday: Harley-Davidson, Illumina, TechnipFMC, Upstart, and DraftKings
StockStory · 7h ago
Barclays Adjusts Illumina Price Target to $200 From $160, Maintains Underweight Rating
MT Newswires · 15h ago
Illumina (ILMN) Shares Skyrocket, What You Need To Know
StockStory · 1d ago
Why PacBio (PACB) Stock Is Trading Up Today
StockStory · 1d ago
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
GlobeNewswire · 1d ago
Illumina's Clinical Sequencing Revenue Seen as Durable Mid-Teens Grower, RBC Capital Markets Says
MT Newswires · 1d ago
EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease
PR Newswire · 2d ago
EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease
PR Newswire · 2d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.